SCB 10X, the disruptive technology investment arm of SCBX Group, announced its participation in the $50 million Series B ...

An upcoming webinar will demonstrate how the recently launched Veo3.1 can help generate cinematic video at scale and even ...

Fintel reports that on November 4, 2025, Stifel maintained coverage of Vertex (NasdaqGM:VERX) with a Hold recommendation.

Fintel reports that on November 4, 2025, Citizens maintained coverage of Vertex (NasdaqGM:VERX) with a Market Outperform ...

The stock's fall snapped a three-day winning streak.

Vertex Pharmaceuticals (VRTX) is rated as a "Strong Buy" due to robust revenue growth and multiple expansion opportunities ...

While the launches of Journavx and Casgevy have started to build steam, “investors may not be inclined to look past the clear revenue misses,” wrote a Raymond James analyst.

AI is revolutionizing how the Department of Homeland Security protects the U.S. via better border and airport security, as examples.

Vertex (NASDAQ: VERX) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table below ...

BOSTON (AP) — BOSTON (AP) — Vertex Pharmaceuticals Inc. (VRTX) on Monday reported third-quarter net income of $1.08 billion. On a per-share basis, the Boston-based company said it had profit of $4.20.

Discover Vertex’s Q3 2025 earnings: strong cloud growth, new CEO, $150M share buyback, and AI investments amid guidance cuts.

Thankfully, some companies can handle an inflationary environment and perform well throughout, while still registering the 12 ...